Back to Treatments

Treatment

Famotidine (H2-Receptor Antagonist)

1
Conditions
4
Trials
100K
Participants
80%
Average Safety

Condition Evidence

Peptic ulcer disease

4 trials · 100K participants

70% effectiveness · 80% safety
Famotidine (H2-Receptor Antagonist) | DFDA